Popular topics to explore

★All TopicsEquity ResearchFundamental ViewsHidden GemsIndex StrategiesIPOMacro ViewsMiscellaneousPersonal FinancePost-Closing CommentaryPre-Opening CommentaryPsychology of MoneySector BreakoutStock In NewsTechnical ViewsTime To ExitToday's Trading SetupTrending SectorsWatch Out For
‹ All Posts
Kundan Motwani
Kundan Motwani

22nd May · SEBI-Registered Analyst

LUPIN:

CO RECEIVES CHINA APPROVAL FOR OSELTAMIVIR PHOSPHATE ORAL SUSPENSION $LUPIN

#WatchOutFor#StockInNews
512 likes·64 comments